DARA Share Price

Open 0.00 Change Price %
High 0.95 1 Day 0.00 0.00
Low 0.88 1 Week 0.00 0.00
Close 0.88 1 Month 0.00 0.00
Volume 391218 1 Year 0.00 0.00
52 Week High 10.81
52 Week Low 5.92
DARA Important Levels
Resistance 2 0.94
Resistance 1 0.92
Pivot 0.90
Support 1 0.84
Support 2 0.82
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
WRES 0.09 0.00%
SIRI 4.41 1.85%
QQQ 116.87 0.23%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ECTE 0.14 40.00%
BNSO 3.57 31.25%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
CRDS 5.45 25.87%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
IMRS 0.02 -33.33%
More..

DARA Biosciences, Inc. (NASDAQ: DARA)

DARA Technical Analysis 3
As on 4th Dec 2015 DARA Share Price closed @ 0.88 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.85 & Buy for SHORT-TERM with Stoploss of 0.86 we also expect STOCK to react on Following IMPORTANT LEVELS.
DARA Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
DARA Other Details
Segment EQ
Market Capital 11975324.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.darabiosciences.com
DARA Address
DARA
8601 Six Forks Road
Suite 160
Raleigh, NC 27615
United States
Phone: 919-872-5578
Fax: 919-861-0239
DARA Latest News
DARA BioSciences Announces Stockholder Approval of Merger With Midatech   Marketwired (press release)   - 03rd Dec 15
Stock Update (NASDAQ:DARA): DARA Biosciences Inc Announces Second Quarter 2015 ...   Smarter Analyst   - 13th Aug 15
DARA BIOSCIENCES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces ...   PR Newswire (press release)   - 10th Jun 15
DARA BioSciences (DARA), Midatech Pharma Enter Merger Agreement   StreetInsider.com   - 04th Jun 15
Why I Decided To Invest In Dara Biosciences (DARA)   Seeking Alpha (registration)   - 24th Mar 15
DARA BioSciences Nabs US Rights to Oral Thrush Drug   Xconomy   - 10th Mar 15
DARA BioSciences Launches Oral Mucositis Care App to Provide Cancer Patients ...   Business Wire (press release)   - 03rd Jun 14
DARA BioSciences Obtains US Rights to Co-Promote Bionect(R), an FDA Approved ...   GlobeNewsWire (press release)   - 26th Mar 12
DARA BioSciences Announces Acquisition of US Marketing Rights to Soltamox(TM ...   GlobeNewsWire (press release)   - 17th Jan 12
Darat Jordan Holdings Co. PLC   MarketWatch   - 22nd Dec 09
Interactive Technical Analysis Chart DARA Biosciences, Inc. ( DARA NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on DARA Biosciences, Inc.
DARA Business Profile
DARA BioSciences, Inc. is a specialty pharmaceutical company primarily focused on the commercialization of oncology treatment and oncology supportive care pharmaceutical products. The Company has a clinical development asset, KRN5500, which is a Phase II product candidate targeted for treating cancer patients with painful treatment-refractory chronic chemotherapy induced peripheral neuropathy (CCIPN). Its primary focus is on the commercialization of the oncology treatment and oncology supportive care pharmaceutical products, which include Soltamox, Cancer support therapeutics and Three Mission Pharmacal products. The Company�s oral liquid products can provide a alternative to solid dose formulations for those patients with dysphagia, or difficulty swallowing, or those who simply prefer to take drug products in liquid form.